Sa1767 – Somascan As a Discovery Platform to Identify Predictive Serum Proteomic Biomarkers of Infliximab Response in Pediatric Patients with Crohn's Disease
Tina L. Morhardt(AbbVie (United States)), Harland S. Winter(Massachusetts General Hospital), Gábor Veres(Southwest General Health Center), Towia A. Libermann(Beth Israel Deaconess Medical Center), Xi Li, Hasan H. Otu, Xuesong Gu(Beth Israel Deaconess Medical Center), Simon T. Dillon(Beth Israel Deaconess Medical Center)
Cited by 0
Related Papers
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
|Science|2009|1.5k
ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents
|Journal of Pediatric Gastroenterology and Nutrition|2013|1.4k
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
|Journal of Crohn s and Colitis|2014|1.1k